Effect of N-Acetylcysteine in Attenuating Ischemic Reperfusion Injury in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass

Annals of Vascular Surgery

Volumn 23, Issue 5, 2009, Pages 645-651

  Prabhu, A ^a   Sujatha, D I ^b   Kanagarajan, N ^b   Vijayalakshmi, M A ^c   Ninan, Benjamin ^b  

^a MMM Academy of Medical Sciences   (India)

^b Madras Medical Mission ^*  (India)

^c VIT UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; MALONALDEHYDE; TROPONIN I;

ADULT; ARTICLE; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PROTECTION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY;

ACETYLCYSTEINE; ANTIOXIDANTS; BIOLOGICAL MARKERS; CARDIOPULMONARY BYPASS; CARDIOTONIC AGENTS; CATALASE; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEART ARREST, INDUCED; HEMODYNAMICS; HUMANS; MALONDIALDEHYDE; MIDDLE AGED; MYOCARDIAL REPERFUSION INJURY; OXIDATIVE STRESS; PROSPECTIVE STUDIES; STROKE VOLUME; SUPEROXIDE DISMUTASE; TIME FACTORS; TREATMENT OUTCOME; TROPONIN I; VENTRICULAR FUNCTION, LEFT;

EID: 69749094651     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.avsg.2008.12.005     Document Type: Article

References (33)

1. Hansen P.R. Myocardial reperfusion injury: experimental evidence and clinical relevance. Eur Heart J 16 (1995) 734-740
2. Bolli R. Oxygen-derived free radicals and myocardial reperfusion injury: an overview. Cardiovasc Drugs Ther 262 (1991) 249-268
3. Halliwell B., Gutteridge J.M.C., Cross C.E., et al. Free radicals, antioxidants and human diseases: where are we now. J Lab Clin Med 119 (1992) 598-620
4. Ambrosio G., Weisfeldt M.L., Jacobus W.E., et al. Evidence for a reversible oxygen radical-mediated component of reperfusion injury: reduction by recombinant human superoxidedismutase administered at the time of reflow. Circulation 75 (1987) 282-291
5. Kiziltepe U., Tunctan B., Eyileten Z.B., et al. Efficiency of L-arginine enriched cardioplegia and non cardioplegic reperfusion in ischemic hearts. Int J Cardiol 97 (2004) 93-100
6. Butterworth J., Legault C., Stump D.A., et al. A randomized blinded trial of the antioxidant pegorgotein: no reduction in neurophysiological deficits, inotropic drug support or myocardial ischemia after coronary artery bypass surgery. J Cardiothorac Vasc Anesth 13 (1999) 690-694
7. Lassnigg A., Punz A., Barker R., et al. Influence of vitamin E supplementation in cardiac surgery on oxidative stress; a double-blinded randomized, controlled study. Br. J Anaesth 90 (2003) 148-154
8. Cotgreave I.A. N-Acetyl cysteine: pharmacological considerations and experimental and clinical applications. Adv Pharmacol 38 (1997) 205-227
9. Miquel J., Ferrandiz M.L., De Juan E., et al. N-Acetyl cysteine protects against age related decline of oxidative phosphorylation in liver mitochondria. Eur. J Pharmacol 292 (1995) 333-335
10. Sochman J. N-Acetyl cysteine in acute cardiology: ten years later. J Am Coll Cardiol 39 (2002) 1422-1428
11. Fischer U.M., Cox C.S., Allen S.J., et al. The antioxidant N-acetyl cysteine preserves myocardial function and diminishes oxidative stress after cardioplegia arrest. J Thorac Cardiovasc Surg 126 (2003) 1483-1488
12. Sucu N., Cinel I., Unlu A., et al. N-Acetyl cysteine for preventing pump-induced oxidoinflammatory response during cardiopulmonary bypass. Surg Today 34 (2004) 237-242
13. International Committee for Standardization in Hemotology. Recommondations for hemoglobinometry in human blood. Br. J Haematol 13 (1967) 71-79
14. Sinha A.K. Colorimetric assay of catalase. Anal Biochem 47 (1972) 389-394
15. Mishra H.P., and Fridovich I. The role of superoxide anion in the auto-oxidation of the epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 247 (1972) 3170-3175
16. Moron M.S., Depierre J.W., and Mannervik B. Levels of glutathione, glutathione reductase and glutathione-S-transferase activities in rat lung and liver. Biochim Biophys Acta 582 (1979) 67-68
17. Rotruck J.T., Pope A.L., Gauther H.E., et al. Selenium: biochemical roles as a component of glutathione peroxidase. Science 179 (1973) 588-590
18. 6. Clin Chem. 22 (1976) 327-335
19. Okhawa H., Ohishi N., and Yagi K. Reaction of linoleic and hydroperoxide with thiobarbutyric acid. J Lipid Res. 19 (1978) 1053-1057
20. Clermont G., Vergely C., Jazayeri S., et al. Systemic free radical activation is major event involved in myocardial oxidative stress related to cardiopulmonary bypass. Anesthesiology 96 (2002) 80-87
21. Ochoa J.J., Vilchez M.J., Ibanez-Quiles S., et al. Oxidative stress is evident in erythrocytes as well as plasma in patients undergoing heart surgery involving cardiopulmonary bypass. Free Radic Res. 37 (2003) 11-17
22. Toivonen H.J., and Ahotupa M. Free radical reaction products and antioxidant capacity in arterial plasma during coronary artery bypass grafting. J Thorac Cardiovasc Surg 108 (1994) 140-147
23. Kormaz I., Pulathan Z., Usta S., et al. Cardioprotective effect of cold blood cardioplegia enriched with N-acetyl cysteine during coronary artery bypass grafting. Ann Thorac Surg 81 (2006) 613-618
24. Menasche P., Grousset C., Gaudel Y., et al. Maintenance of myocardial thiol pool by N-acetyl cysteine. An effective means of improving cardioplegic protection. J Thorac Cardiovasc Surg 103 (1992) 936-944
25. Aruoma O.I., Halliwell B., Hoey B.M., et al. The antioxidant action of N-acetyl cysteine: its reaction with hydrogen peroxide, hydroxy radical, superoxide and hypochlorus acid. Free Radic Biol Med 6 (1989) 593-597
26. Luyten C.R., Van Overveld F.J., DeBacker L.A., et al. Antioxidant defense during cardiopulmonary bypass surgery. Eur J Cardiovasc Thorac Surg 27 (2005) 611-616
27. Das K.C., Lewis-Molock Y., and White C.W. Activation of NF-κB and elevation of MnSOD gene expression by thiol reducing agents in lung adenocarcinoma (A549) cells. Am J Physiol Lung Cell Mol Physiol 269 (1995) 588-602
28. Jablonska M., Sztanke K., Pasternak W., et al. Changes in antioxidant enzyme activities in erythrocytes in patients undergoing CABG-a pilot study. Appl Cardiopulm Pathophysiol 12 (2008) 13-19
29. Demircan S., Yazici M., Diraman E., et al. The effect of glucose insulin potassium treatment on myocardial oxidative stress in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Coron Artery Dis 19 (2008) 99-104
30. Blaustein A., Deneke S.M., Stolz R.I., et al. Myocardial glutathione depletion impairs recovery after short periods of ischemia. Circulation 80 (1989) 1449-1457
31. Adams J.E., Bodar G.S., Davila-Roman V.G., et al. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 88 (1993) 101-106
32. Ismail H., Louis M.S., Micheal C., et al. Effect of intravenous N-acetyl cysteine outcomes after coronary artery bypass surgery-a randomized, double blind, placebo controlled clinical trial. J Thorac Cardiovasc Surg 133 (2007) 7-12
33. Forbes R.A., Steenbergen C., and Murphy E. Diazoxide-induced cardioprotection requires signalling through a redox sensitive mechanism. Circ Res. 88 (2001) 802-809